Related Experiment Video

Updated: Jul 14, 2026

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
07:40

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

[How I explore...the revisited toxic path of scleroderma]

P Quatresooz1, P Paquet, C Piérard-Franchimont

  • 1CHU du Sart Tilman, Service de Dermatopathologie, Liège, Belgique. pascale.quatresooz@chu.ulg.ac.be

Revue Medicale De Liege
|May 22, 2007
PubMed

Insights

Scleroderma encompasses diverse diseases with varying prognoses and unclear origins. While toxic exposures are suspected, particularly for progressive systemic scleroderma, definitive links to specific chemicals remain unsettled.

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Context:

  • Scleroderma represents a spectrum of autoimmune diseases characterized by fibrosis.
  • Clinical presentation and prognosis vary significantly among different scleroderma subtypes.
  • The etiology of scleroderma remains largely unknown, posing diagnostic and therapeutic challenges.

Purpose:

  • To review the current understanding of scleroderma classification and etiology.
  • To discuss the potential role of environmental factors, specifically toxic exposures, in scleroderma pathogenesis.
  • To highlight the challenges in establishing causal links between suspected agents and disease development.

Summary:

  • Scleroderma is a group of diseases with distinct clinical features and prognostic outcomes.
  • The underlying causes of these conditions are not well understood.
  • Toxicological factors, especially in progressive systemic scleroderma, are hypothesized but not definitively proven.

Impact:

  • Improved understanding of scleroderma heterogeneity and potential environmental triggers.
  • Highlights the need for further research into the specific etiological agents of scleroderma.
  • Informs clinical suspicion and diagnostic approaches for patients with suspected scleroderma.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...